TNF-α expression in the UCB-MSCs as stable source inhibits gastric cancers growth in nude mice

Cancer Investigation

Volumn 30, Issue 6, 2012, Pages 463-472

  Mao, Weizheng ^a   Zhu, Xinhong ^a   Tang, Dongqi ^b   Zhao, Yuanyuan ^c   Zhao, Baocheng ^d   Ma, Guiliang ^a   Zhang, Xuebin ^a   An, Gang ^c   Li, Yang ^a  

^a QINGDAO MUNICIPAL HOSPITAL   (China)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c QINGDAO UNIVERSITY   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Gastric cancer; Lentiviral vector; Tumor necrosis factor (TNF ); Umbilical cord blood mesenchymal stem cells (UCB MSCs)

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BYSTANDER EFFECT; CANCER CELL CULTURE; CANCER GROWTH; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; GENE DELIVERY SYSTEM; HUMAN; HUMAN CELL; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUDE MOUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STOMACH CANCER; TREATMENT OUTCOME; UMBILICAL CORD BLOOD; UMBILICAL CORD BLOOD MESENCHYMAL STEM CELL;

ANIMALS; CELL LINE, TUMOR; FETAL BLOOD; GENE THERAPY; GENE TRANSFER TECHNIQUES; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; STOMACH NEOPLASMS; TRANSFECTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861735992     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.3109/07357907.2012.675385     Document Type: Article

References (37)

1. Alberts SR, Cervantes A, van De Velde CJ. Gastric cancer: Epidemiology, pathology and treatment. Ann Oncol 2003;14(Suppl. 2):ii31-ii36. (Pubitemid 36874136)
2. Zhang H, Sun LL, Meng YL, Song GY, Hu JJ, Lu P, Ji B. Survival trends in gastric cancer patients of Northeast China.World J Gastroenterol 2011;17(27):3257-3262.
3. Sutter AP, Fechner H. Gene therapy for gastric cancer: Is it promising?World J Gastroenterol 2006;12:380-387. (Pubitemid 43329253)
4. Tanaka H, Yashiro M, Sunami T, Sakate Y, Kosaka K, Hirakawa K. ICAM-2 gene therapy for peritoneal dissemination of scirrhous gastric carcinoma. Clin Cancer Res 2004;10:4885-4892. (Pubitemid 38955543)
5. Heideman DA, van Beusechem VW, Bloemena E, Snijders PJ, Craanen ME, Offerhaus GJ, Derksen PW, De Bruin M, Witlox MA, Molenaar B, Meijer CJ, Gerritsen WR. Suppression of tumor growth, invasion and angiogenesis of human gastric cancer by adenovirus-mediated expression of NK4. J Gene Med 2004;3:317-327. (Pubitemid 40228049)
6. Khalighinejad N, Hariri H, Behnamfar O, Yousefi A, Momeni A. Adenoviral gene therapy in gastric cancer: A review.World J Gastroenterol 2008;14:180-184. (Pubitemid 351314296)
7. Tanaka T, Huang J, Hirai S, Kuroki M, Watanabe N. Carcinoembryonic antigen-Targeted selective gene therapy for gastric cancer through FZ33 fiber-modified adenovirus vectors. Clin Cancer Res 2006;12:3803-3813. (Pubitemid 44000262)
8. Than SS, Kataoka K, Sakaguchi M, Murata H, Abarzua F, Taketa C, Du G, Yashiro M, Yanagihara K, Nasu Y, Kumon H, Huh NH. Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma. Oncol Rep 2011;25:989-995.
9. Pereboeva L, Komarova S, Mikheeva G, Krasnykh V, Curiel DT. Approaches to utilizemesenchymal progenitor cells as cellular vehicles. Stem Cells 2003;21:389-404. (Pubitemid 36793483)
10. Aboody KS, Brown A, Rainov NG, Bower KA, Liu S, Yang W, Small JE, Herrlinger U, Ourednik V, Black PM, Breakefield XO, Snyder EY. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci U S A 2000;97:12846-12851.
11. Nakamizo A, Marini F, Amano T, Khan A, Studeny M, Gumin J, Chen J, Hentschel S, Vecil G, Dembinski J, Andreeff M, Lang FF. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005;65:3307-3318. (Pubitemid 40524615)
12. Studeny M, Marini FC, Champlin RE, Zompetta C, Fidler IJ, Andreeff M. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-β delivery into tumors. Cancer Res 2002;62:3603-3608. (Pubitemid 34728832)
13. Miletic H, Fischer Y, Litwak S, Giroglou T, Waerzeggers Y, Winkeler A. Bystander killing of malignant glioma by bone marrow-derived tumor-iniltrating progenitor cells expressing a suicide gene. MolTher 2007;15:1373-1381. (Pubitemid 46965333)
14. Kern S, Eichler H, Stoeve J, Kl̈uter H, Bieback K. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue. Stem Cells 2006;24:1294-1301. (Pubitemid 44464698)
15. Mao WZ, Chen JQ. Effect of activated greater omental milky spots and peritoneal macrophages on tumoricidal activity against gastric carcinoma SGC-7901 in mice. Chin J Oncol 2003;25(3):225-229.
16. Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci U S A 1975;72:3666-3670.
17. Eggermont AM, Schraffordt KH, Líenard D, Kroon BB, van Geel AN, Hoekstra HJ, Lejeune FJ. Isolated limb perfusion with high-dose tumor necrosis factor-Alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: A multicenter trial. J Clin Oncol 1996;10:2653-2665. (Pubitemid 26329649)
18. Younes A,KadinME. Emerging applications of the tumor necrosis factor family of ligands and receptors in cancer therapy. J Clin Oncol 2003;21:3526-3534. (Pubitemid 46594087)
19. Eggermont AM, De Wilt JH, ten Hagen TL. Current uses of isolated limb perfusion in the clinic and a model system for new strategies. Lancet Oncol 2003;4:429-437. (Pubitemid 36833685)
20. Eggermont AM, ten Hagen TL. Tumor necrosis factor-based isolated limb perfusion for soft tissue sarcoma and melanoma: Ten years of successful antivascular therapy. Curr Oncol Rep 2003;5:79-80. (Pubitemid 38898770)
21. Terai M, Uyama T, Sugiki T, Li XK, Umezawa A, Kiyono T. Immortalization of human fetal cells: The life span of umbilical cord blood-derived cells can be prolonged without manipulating p16INK4a/RB braking pathway. Mol Biol Cell 2005;16: 1491-1499. (Pubitemid 40349582)
22. Nakamura K, Ito Y, Kawano Y, Kurozumi K, Kobune M, Tsuda H, Bizen A, Honmou O, Niitsu Y, Hamada H. Antitumor effect of genetically engineered mesenchymal stem cells in a rat glioma model. Gene Ther 2004;11:1155-1164. (Pubitemid 39117311)
23. Wolf D, Rumpold H, Koeck R, Gunsilius E. Mesenchymal stem cells: potential precursors for tumor stroma and targeteddelivery vehicles for anticancer agents. J Natil Cancer Inst 2005;97:540-542. (Pubitemid 40590437)
24. Zhao BC, Wang ZJ, Ma HC, Han JG, Zhao B, Xu HM, Mao WZ. CXCR4/SDF-1 axis is involved in the lymph node metastasis of gastric carcinoma. World J Gastroenterol 2011;19: 2389-2396.
25. Menon LG, Picinich S, Koneru R, Gao H, Lin SY, Koneru M, Mayer-Kuckuk P, Glod J, Banerjee D. Differential gene expression associated with migration of mesenchymal stem cells to conditionedmediumfrom tumor cells or bonemarrow cells. StemCells 2007;25:520-528. (Pubitemid 46232808)
26. Teicher BA, Fricker SP. CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 2010;11:2927-2931.
27. Nishida S, Endo N, Yamagiwa H, Tanizawa T, Takahashi HE. Number of osteoprogenitor cells in human bone marrow markedly decreases after skeletal maturation. J BoneMinerMetab 1999;17:171-177. (Pubitemid 29403926)
28. Mueller SM, Glowacki J. Age-related decline in the osteogenic potential of human bone marrow cells cultured in three-dimensional collagen sponges. J Cell Biochem 2001;82:583-590. (Pubitemid 32720674)
29. Stenderup K, Justesen J, Clausen C, Kassem M. Aging is associated with decreased maximal life span and accelerated senescence of bone marrow stromal cells. Bone 2003;33:919-926. (Pubitemid 37543568)
30. Rubinstein P, Rosenfeld RE, Adamson JW, Stevens CE. Stored placental blood for unrelated bone marrow reconstitution. Blood 1993;81:1679-1690. (Pubitemid 23101579)
31. Huang JL, Yang SX. Safety of umbilical cord blood-derived mesenchymal stem cells (MSCs) following 5-Azaserine induction and inhibition of human cardiac myocyte apoptosis by MSCs. Saudi Med J 2009;30:1144-1149.
32. SethiG, Sung B, KunnumakkaraAB,Aggarwal BB. Targeting TNF for treatment of cancer and autoimmunity. Adv Exp Med Biol 2009;647:37-51.
33. Grewal IS. Overview of TNF superfamily: A chest full of potential therapeutic targets. Adv Exp Med Biol 2009;647:1-7.
34. Bertazza L, Mocellin S. The dual role of tumor necrosis factor (TNF) in cancer biology. Curr Med Chem 2010;17:3337-3352.
35. SethiG, Sung B, KunnumakkaraAB,Aggarwal BB. Targeting TNF for treatment of cancer and autoimmunity. Adv Exp Med Biol 2009;647:37-51.
36. Kurzrock R, Rosenblum MG, Sherwin SA, Rios A, Talpaz M, Quesada JR. Pharmacokinetics, single-dose tolerance and biological activity of recombinant gamma-interferon in cancer patients. Cancer Res 1985;45:2866-2872. (Pubitemid 15232762)
37. Mocellin S, Pilati P, Nitti D. Towards the development of tumor necrosis factor (TNF) sensitizers: making TNF work against cancer. Current Pharm Design 2007;13:537-551. (Pubitemid 46477756)